Skip to main content
logo
Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
130.13
-2.74 (-2.06%)
At close: Jul 7, 2025, 4:00 PM
130.45
+0.32 (0.25%)
Pre-market: Jul 8, 2025, 7:23 AM EDT

Biogen Revenue by Segment
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Multiple Sclerosis
4.23B 4.35B 4.45B 4.55B 4.61B 4.66B 4.76B 4.94B
Multiple Sclerosis Growth
-8.37% -6.70% -6.60% -7.90% -10.62% -14.15% -16.30% -16.29%
Other
2.64B 2.49B 2.39B 2.42B 2.47B 2.59B 2.67B 2.50B
Other Growth
7.12% -3.89% -10.48% -2.92% 1.98% 18.45% 28.19% 18.11%
Rare Disease
2.13B 1.99B 1.87B 1.82B 1.72B 1.74B 1.79B 1.77B
Rare Disease Growth
23.36% 13.99% 4.21% 2.78% -2.26% -2.77% 0.82% -0.96%
Biosimilars
777.50M 793.60M 779.80M 777.50M 774.50M 770.00M 756.60M 749.90M
Biosimilars Growth
0.39% 3.06% 3.07% 3.68% 3.38% 2.52% -5.09% -7.69%

Revenue by Geography
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
International
3.97B 3.97B 3.95B 4.01B 4.01B 4.11B 4.18B 4.28B
International Growth
-0.90% -3.39% -5.42% -6.34% -8.77% -9.25% -11.29% -11.28%
United States
3.25B 3.24B 3.25B 3.23B 3.19B 3.14B 3.14B 3.20B
United States Growth
1.85% 3.05% 3.53% 0.92% -3.32% -9.45% -12.08% -13.40%
Other Geographic
2.59B 2.46B 2.39B 2.42B 2.47B 2.59B 2.67B 2.50B
Other Geographic Growth
4.90% -4.87% -10.48% -2.92% 1.98% 18.45% 28.19% 18.11%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.